vimarsana.com
Home
Live Updates
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success - NeuroBo Pharmaceuticals (NASDAQ:NRBO) : vimarsana.com
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success - NeuroBo Pharmaceuticals (NASDAQ:NRBO)
NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Novo Nordisk ,
Neurobo Pharmaceuticals Inc ,
Protein Coupled Receptor ,
Price Action ,
vimarsana.com © 2020. All Rights Reserved.